DEVA Holding is a well-established pharmaceutical manufacturer in Türkiye since 1958. With the main area of operations including manufacturing and marketing medicinal products for humans, it also manufactures veterinary medicines, eau de Cologne, and medical ampoules.

Currently, its product portfolio contains more than 650 products in 14 therapeutic areas.

With progressively expanding regional growth and export operations, DEVA Holding is the holder of 1,119 marketing authorizations in 65 countries, including the USA, Switzerland, Germany. Founded under the brand name of Devatis in Germany and Switzerland, the company received registration approval in 2018 and having been established in the USA under the same name, accelerated its activities. Currently, exports pharmaceuticals and pharmaceutical raw materials to more than 60 countries.

DEVA Holding focuses on R&D to improve access to medicines for patients, and all of its manufacturing facilities are certified compliant with the European GMP and US FDA.

DEVA Holding develops high-quality and innovative products with its award-winning R&D center, strong staff of well-trained employees who are experts in their respective fields, and full-fledged laboratories and manufacturing sites equipped with cutting-edge technology.

Undertaking manufacturing operations at facilities in Çerkezköy and Kartepe, DEVA Holding holds an annual output capacity of 620 million units of medicines.

Website